Skip to main content
Janssen is now J&J Innovative Medicine.  
 
 
 
 
MENU
VISIT JANSSEN GLOBAL

EMEA
change location▼

Search
Search

VISIT JANSSEN GLOBAL

News center landing

NEWS CENTRE - JANSSEN NEWS

Featured Stories

 
  • covid vaccine

    Learn how a vaccine works and how it differs from our immune system

    back to Janssen EMEA stories back to Janssen EMEA stories

    Read More
  • micro IDV

    Will Ebola continue to re-emerge

    back to Janssen EMEA stories Allitia Di Bernardo, EMEA Therapeutic Area Lead, CNS, IDV, and PAH, at Janssen Since...

    Read More
  • HIV

    Can we end the AIDS epidemic?

    back to Janssen EMEA stories In 2014, UNAIDS announced its intention to end the AIDS epidemic by 2030. 1 Now, 6 years...

    Read More
View More Stories

All Stories

Cycling for Children is back for its sixth edition on 6-8 October 2023

back to Janssen EMEA stories */ On Friday, Saturday & Sunday 6-8th of October 2023, Janssen and MedTech colleagues...

Top 8 Janssen EMEA's must-reads

back to Janssen EMEA stories At Janssen EMEA, we are not only avid readers, but we love to create new reading content...

Johnson & Johnson Makes significant Progress Towards 100% Renewable Electricity Goal with New Wind and Solar Power Purchase Agreements

back to Janssen EMEA stories As a leader in the healthcare industry, we at Johnson & Johnson know that human health...

Cycling for Children is back on 10-12 September

back to Janssen EMEA stories */ On Friday, Saturday & Sunday 10-12 September 2021 , Janssen EMEA’s flagship...

Health for Humanity report 2020 

back to Janssen EMEA stories We’ve just released our Health for Humanity report for 2020 – and set out our new Health...

New Methods of Collaboration in AI and Data Science

back to Janssen EMEA stories We’re very excited about the latest research collaboration with Janssen France between The...

More stories

Transparency

Janssen EMEA is committed to increasing transparency when it comes to the relationships between pharmaceutical companies and HCPs/HCOs. Through the disclosure of transfers of value, we aim to build a better understanding of these collaborations and more recognition of their value to patient care.

 

Learn more

 

Stories about